Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mario Mancino"'
Autor:
Patricia Jauregui, Aleix Noguera-Castells, Raul Alonso, Silvia Menendez, Laia Serrano, Elisabet Ametller, Ana Lluch, L. Alex Gaither, Federico Rojo, Paloma Bragado, Pere Gascón, Leire Recalde-Percaz, Mario Mancino, Ana Rovira, Estel Enreig, Núria Moragas, Joan Albanell, Patricia Fernández-Nogueira, Vanessa Almendro, Anke Bill, Gemma Fuster, Anna López-Plana
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Purpose:Despite the therapeutic success of existing HER2-targeted therapies, tumors invariably relapse. This study aimed at identifying new mechanisms responsible for HER2-targeted therapy resistance.Experimental Design:We have used a platform of HER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e227e565ba327bbbd44f395147ae2e89
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4333
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4333
Autor:
Aleix Noguera-Castells, Elisabet Megías-Roda, Gemma Fuster, Anna López-Plana, Tatiana Erazo, Pau Muñoz-Guardiola, Héctor Pérez-Montoyo, Carles Domenech, Patricia Fernández-Nogueira, Jose Alfon, Pere Gascón, Paloma Bragado, Marc Yeste-Velasco, Leire Recalde-Percaz, Teresa Moran, Ernest Nadal, Mariana Gomez-Ferreria, Patricia Jauregui, Mario Mancino, Jose M. Lizcano, Elisabet Ametller, Sonia Solé-Sánchez, Núria Moragas‐Garcia
Publikováno v:
International journal of cancerReferences. 147(4)
Around 40% of newly diagnosed lung cancer patients are Stage IV, where the improvement of survival and reduction of disease-related adverse events is the main goal for oncologists. In this scenario, we present preclinical evidence supporting the use